Asahi Kasei Pharma to Solicit Proposals for Drug Discovery Research

Asahi Kasei Pharma is publicly calling for new proposals related to drug development research as part its efforts for open innovation, to promote pharmaceutical research and...

Shifting from treating symptoms to curing diseases and making Europe the world leader in Advanced Therapies is the aspiration of RESTORE – the Large-Scale Research Initiative, led by Charité. On February 8, the European Commission (EC) backed that...

If awarded, you will:

• Co-develop and validate the solution within the GHU Paris, GCSMS 91 or FOCH Hospital and GIP RESAH.
• Receive funding up to 60.000€ [40.000€ for Challenges 1 to 4 and 60.000€ for Challenge 5, completed with a maximum funding...

Adrenomed AG, the vascular integrity company, today announced that the Phase II clinical trial design of AdrenOSS-II was published by the peer-reviewed open access journal BMJ Open. The currently ongoing Phase II trial is conducted to assess the...

Since the beginning of February this year, Christine Goffinet has been the BIH Professor of Virology at the Berlin Institute of Health (BIH) and the Institute of Virology at Charité – Universitätsmedizin Berlin. She is conducting research into the...

Das von Horizon 2020 geförderte Projekt STARS "Empowering Patients by Professional Stress Avoidance and Recovery Services" wird die Ausschreibung am 1. Februar 2019 veröffentlichen. Die Frist für die Einreichung von Vorschlägen endet am 30. April...

Several research groups at Berlin Institute of Health (BIH) are working on digitally combating cancer. The main goal is to combine and jointly evaluate existing information. With 500,000 new cancer cases every year in Germany alone, it is worthwhile...

Researchers from Charité – Universitätsmedizin Berlin have discovered a protective mechanism which is used by the body to protect intestinal stem cells from turning cancerous. The body’s innate immune system was found to play a pivotal role in this...